Eyal Grunebaum MD

We wanted again to thank you for the tremendous assistance you and your team have provided to us while developing a novel lenti-virus based treatment for a rare lethal human immune defect. From optimizing the gene sequence and designing the vector, through the production of high titer viruses and eventually even the transduction protocol and details, your advice and “hands-on” approach has been critical to the success of the project. Our team was particularly impressed by your rapid response to queries that we had, relying heavily on your extensive experience and expertise in the area of lenti-virus production and usage. We will undoubtedly use your services again, and will suggest to our many collaborators and colleagues to do the same.